Clinical Trials Browser

Phase 2 × Breast Neoplasms × Phantoms, Imaging × Clear all

NCT02849496 2025-11-24

Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer

Phase 2 Active not recruiting

Breast Neoplasms